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PT 563 
Cardiopulmonary Physical Therapy 
Fall 2 0 1 4 - Block 1
I. Instructors: James J Laskin, PT, PhD




III. Meeting Time: Tuesday & Thursday 8:10-12:00
Room 114/018
IV. Resources accessed:
Moore KL. Clinically Oriented Anatomy 
O'Sullivan, S. Physical Rehabilitation
American Physical Therapy Association Guide to  PT Practice 
Ciccone, C.D. Pharmacology in Rehabilitation 
Perison FM, Fairchild SL. Principles and Techniques o f Patient Care 
Goodman and Snyder. D ifferential Diagnosis fo r Physical Therapists
Hall and Brody. Therapeutic Exercise 
Kisner and Colby. Therapeutic Exercise
Readings: Selected required readings w ill be available in the required texts. 
Required articles and/or other selected readings w ill be placed on Moodle 
online; once you log on fo llow  the PT 563 links. Required readings must be 
completed prior to  class.
VI. Course Description: This course addresses the physical therapy management of persons 
w ith  dysfunction of the cardiac and/or pulmonary systems, and related pathologies in terms of 
pathology, assessment, differential diagnosis, treatm ent, and pharmacology. Case studies or 
client examples are used to  apply the processes o f examination, evaluation, diagnosis, 
prognosis, intervention, and outcomes document. Management by other health professional 
team members will be discussed in the context o f comprehensive care. This course is designed 
to  assist in the synthesis o f knowledge and practical experiences in designing and implementing 
rehabilitation programs and exercise interventions as a physical therapist and represents the 




Pulmonary Section Exam 30%
Assignments
NDWC 10%
Pulm Lab 1 7.5%
Pulm Lab 2 7.5%
CV Lab 1 7.5%
CV Lab 2 7.5%
Cardiac Section Exam 30%
VIII. Grading Scale: These course components must be successfully completed w ith  a C or better 
(> 73). Opportunities to  retake tests or the final exam due a failing grade w ill not be available. 
Test and exam results w ill be available on Moodle.







IX. Teaching Methods and Learning Experiences: Lecture/discussion supported w ith  electronic 
media, assigned readings, laboratory experiences.
M ajor educational models introduced include:
•  Health care disablement model
•  Motivational Interviewing
Assignments: There are 5 assignments to  be completed in this course. Four of them are directly 
related to  the in class lab experience and are designed to  help the student better synthesize the 
skills being introduced. The NDWC assignment w ill be used to  integrate the skills and didactic 
content on volunteer clients from  the NDWC. Specifics of the assignment and expectations will 
be provided in class.
Exams: There w ill be 2 section exams: Pulmonary Section and Cardiovascular Section. These will 
be 2 hour exams tha t w ill cover the material covered in tha t section and w ill not be cumulative. 
Questions w ill included: T/F, MC, short answer and case study.
X. Professional Behaviors: Professional behaviors are expected in the course. These include 
(but are not lim ited to): responsibility fo r one's own learning, completion of group and 
individual assignments in a tim ely manner, on tim e attendance unless excused, coming to  class 
prepared, treating fe llow  students, staff, and faculty w ith  respect, receiving and giving 
constructive criticism if appropriate. Please refer to  the "Generic Abilities" section in your 
student handbook.
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Academic Honesty: All students must practice academic honesty. Academic misconduct is 
subject to  an academic penalty by the course instructor and/or a disciplinary sanction by the 
University.
All student need to  be fam iliar w ith  the Student Conduct Code. The Code is available fo r review 
online at http://www.um t.edu/SA/VPSA/index.cfm /page/1321.
Plagiarism is to  be avoided. For information on plagiarism please visit these links: 
h ttp://www.calstate la.edu/centers/w rite cn/plagiarism.htm 
http://www.lib.um t.edu/services/plagiarism /index.htm  
Students w ith  Identified needs:
The UM strives to  make special accommodations fo r students w ith  identified special needs. 
Students w ith  disabilities must register w ith  UM Disability Services fo r Students. Their office is 
the University of Montana's student affairs office, which assures program access to  the 
University by students w ith disabilities. Their website is as follows: http ://life .um t.edu/dss.
XI. Useful Internet Links:
http ://w w w .card iopt.org  
Cardiopulmonary section, APTA
http://www.aacvpr.com /
American Association o f Cardiovascular & Pulmonary Rehabilitation
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PT 563 Cardiopulmonary PT and Pharmacology 
Course Objectives
Code fo r Objectives:
1 - Knowledge and comprehension
2 - Application
3 - Psychomotor
4 - Analysis, synthesis, and evaluation
5 - Affective
A. Physical therapy in cardiopulmonary disease (CC-5.1, 5.10, 5.11, 5.40, 5.45)
(1) 1.0 Describe the scope o f physical therapist practice and the relationship to  other
allied health providers in the context o f cardiopulmonary systems management 
(5.10, 5.11; EXO 8, 9)
(2) 1.1 Differentiate between entry-level and advanced competencies practiced and
use o f other personnel in client care (5.40; EXO 6)
(3) 4.0 Summarize reimbursement issues and use o f selected outcome measures w ith
respect to  patients w ith  cardiovascular and/or pulmonary disease (5.1, 5.45;
EXO 8,12)
B. Health care & disablement models in cardiopulmonary disease (CC-5.22, 5.32, 5.33)
(4) 1.0 Describe ways a diagnosis may guide subsequent management in patients w ith
cardiovascular and/or pulmonary disease (5.32; EXO 2)
(5) 1.1 Describe how prognosis may be determined fo r patients w ith  cardiovascular
and/or pulmonary disease (5.33, EXO 2)
(6) 2.0 Apply the disablement model as described in the Guide to  Physical Therapist
Practice in the management o f people w ith cardiovascular and/or pulmonary 
disease (5.22)
C. Applied anatomy & pathophysiology of cardiopulmonary disease (CC-3, objectives 7-10, EXO 1)
(7) 1.0 Describe the process o f atherosclerosis and contemporary theories o f plaque
rupture
(8) 1.1 Describe the elements of obstructive and resistive diseases and conditions of the
pulmonary system
(9) 1.2 Describe the process o f peripheral arterial and vascular disease and the associated
impairments
(10) 2.0 Classify risk factors fo r the development o f cardiopulmonary and vascular diseases.
D. Essential entry-level skill sets (CC-5.28, 5.29, 5.30, 5.39)
(11) 1.0 Identify evidence of ischemia on an electrocardiogram (5.30e; EXO 2)
(12) 1.1 Differentiate between atrial and ventricular arrhythmia on an electrocardiogram
and make clinical decisions based on analysis (5.30e; EXO 2, 3)
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(13) 1.2 Describe special considerations w ith  assessment and intervention based on the
intensive care environment (lines, tubes, ventilators) (5.30e, w; EXO 3)
(14) 1.3 Identify cardiovascular and pulmonary drugs, adverse effects and physiological
effect associated w ith  exercise (5.28; EXO 3).
(15) 3.0 Demonstrate entry-level skills associated w ith  the physical examination of
people w ith  cardiovascular and/or pulmonary disease (5.30; EXO 2)
(16) 3.1 Describe and demonstrate appropriate airway clearance techniques in the
cardiopulmonary patient population (5.39f, EXO 4)
(16a) 3.2 Demonstrate proper positioning fo r postural drainage (5.39f, EXO 4)
(17) 3.3 Demonstrate the manual techniques o f percussion, vibration, facilitated coughing,
breathing exercises, mediate percussion, and auscultation (5.39f, EXO 4)
E. Examination & Evaluation (CC-5.9, 5.11, 5.12, 5.28, 5.29, 5.30, 5.31, 5.43; EXO 2 - all)
(18) 1.0 Discuss self-monitoring and symptom awareness fo r recognition and
management o f cardiovascular and/or pulmonary issues (5.9)
(19) 1.1 Identify risk factors fo r cardiovascular and pulmonary disease through self-
assessment (5.12)
(20) 1.2 Describe varying issues tha t may affect the physiological responses at rest and
w ith  exercise in clients w ith  cardiovascular and/or pulmonary disease (5.19)
(21) 1.3 Describe responses tha t assess degree o f arousal, attention and cognition in
patients w ith  cardiovascular and/or pulmonary disease (5.30c)
(22) 1.4 Describe special considerations in the assessment o f muscular fitness in patients
w ith  cardiovascular and/or pulmonary disease (5.30m)
(23) 1.5 Describe use o f pain scales to  assess pain associated w ith peripheral vascular
disease, and cardiovascular and/or pulmonary mediated complaints (5.30p)
(24) 1.6 Describe abnormal pulmonary responses to  exercise in patients w ith
cardiovascular and/or pulmonary disease (5.30w)
(25) 2.0 Demonstrate ability to  document cardiopulmonary specific findings (assessment
and exercise response)
(26) 2.1 Demonstrate appropriate patient/client interactions in interview, symptom and
vital signs assessment, airway clearance techniques in clients w ith 
cardiovascular and/or pulmonary disease (5.11)
(27) 2.2 Demonstrate ability to  obtain an accurate history in patients w ith  cardiovascular
and/or pulmonary disease (5.28)
(28) 2.3 Demonstrate ability to  perform a suitable systems review in patients w ith
cardiovascular and/or pulmonary disease (5.29)
(29) 3.0 Demonstrate ability to  assess submaximal and maximal aerobic endurance
through standardized assessment techniques developed fo r patients w ith 
cardiovascular and/or pulmonary disease (5.30a)
(30) 3.1 Describe and demonstrate ability to  accurately assess pulses, venous integrity
and differentiation of lymphatic flow  (5.30e)
(31) 3.4 Describe and demonstrate techniques used to  assess integumentary integrity in
patients w ith  cardiovascular and/or pulmonary disease (5.30j )
(32) 4.0 Classify risk stratification in known disease populations and methods used to
reduce exercise risk (5.43)
(33) 5.0 Demonstrate appropriate professional behavior including nonverbal behaviors.
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F. Therapeutic interventions (CC-5.20, 5.25, 5.27, 5.30, 5.32 through 5.39)
(34) 1.0 Describe the appropriate use o f interventions as described in the Guide to 
Physical Therapist Practice (communication, instruction and interventions) in 
the management of people w ith  cardiovascular and/or pulmonary disease; 
(35) 1.1 Describe and discuss special considerations fo r specific medical diagnoses in 
patients w ith  cardiovascular and pulmonary disease, through analyses of 
current scientific literature (5.20; EXO 3)
(36) 1.2 Describe clinical indicator thresholds and other health risk factors tha t 
necessitate referral to  another health care professional or fu rther examination 
or consultation by a physical therapist (5.27; EXO 10)
(37) 1.3 Considering the stresses that may accompany cardiopulmonary disease and its 
management, describe the potential age related differential responses a 
physical therapist might observe (5.30; EXO 10
(38) 1.4 Describe modifications tha t maybe necessary in vocational and avocational 
activities in the presence o f cardiovascular and/or pulmonary disease (5.38, EXO 4) 
(39) 1.5 Discuss the importance o f fam ily involvement in comprehensive care of patients 
w ith  cardiovascular and/or pulmonary disease (5.34; EXO 8)
(40) 1.6 Considering the stresses that may accompany cardiopulmonary disease and its 
management, describe the potential culturally related issues tha t a physical 
therapist might engage in developing a plan of care (5.34, 5.41; EXO 4)
(41) 1.7 Identify the barriers, concerns, and the remedies associated w ith  unique home 
environment situations (5.30g; EXO 3, 9);
(42) 2.0 Demonstrate ability to  evaluate data from  the examination (history, systems 
review, and tests and measures) to  make clinical judgments in patients w ith 
cardiovascular and/or pulmonary disease (5.31; EXO 2)
(43) 3.0 Demonstrate through role playing appropriate behavior, language, and 
knowledge when describing the treatm ent options fo r cardiopulmonary care 
(5.41;EXO 8).
(44) 3.1 Describe and demonstrate how posture may influence breathing efficiency and 
lower risk o f pulmonary complications (5.39f; EXO 4)
(45) 4.0 Compose 'best practice' strategies fo r clients w ith  specific medical diagnoses 
across cardiovascular and pulmonary disease patterns (5.25; EXO 4)
(46)4.1 Articulate elements o f a physical therapy plan of care that is safe, effective, and 
patient-centered fo r patients w ith  cardiovascular and/or pulmonary disease 
(5.35; EXO 2, 4)
(47) 4.2 Speculate how available resources may influence patient goals and outcomes to 
maximize treatm ent effectiveness and risk reduction (5.36; EXO 3, 4, 12)
(48) 4.3 Assess methods to  m onitor the plan o f care and adapt in response to  patient 
status (5.38; EXO 4, 6)
(49) 4.4 Summarize exercise interventions tha t can be tailored to  achieve optimal client 
goals and outcomes in patients w ith  cardiovascular and/or pulmonary disease 
(5.39a; EXO 3)
(50)4.5 Explain the proper safety considerations cardiopulmonary care including the 
procedures to  follow ing in the case of an emergency (5.43;EXO 4)
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N ote to  s tuden ts  on expecta tions p r io r to  discussion o f assessment and in te rve n tio n : 
From PT 530, rev iew  fundam en ta l p rinc ip les o f exercise tes ting  and p rescrip tion  -  
These princ ip les w ill be applied fo r  c lien ts  w ith  va rious m an ifes ta tions o f 
ca rd iopu lm o na ry  disease.
Class Schedule: (please note th a t there may be some alterations due to guest 
lecturer availability).
Aug. 26 * A & P related to  the Pulmonary System and Disease
* A & P related to  the Pulmonary System and Disease 
Aug. 28 * Physiological monitoring/ICU/CCU
* Pulmonary Examination 
Sept. 2 * Pulmonary Assessment
* Pulmonary Assessment & Lab 
Sept. 4 * Pulmonary Assessment & Lab
* Pulmonary Tests/Procedures 
Sept. 9 * Pulmonary Tests/Procedures
* Pulmonary Conditions
* 1:10-3:00MC visit (Oxygenation lec & Vent demo) - Professor Nick Arthur
Sept. 11 * Pulmonary Conditions
* Pulmonary Rx lec/lab 
Sept. 16 * Pulmonary Rx lec/lab
* The Motivational Interview -  Professor Levison 
Sept. 18 * A & P related to  the cardiovascular system and disease
* Chest assessment/CV auscultation I 
Sept. 23 * Pulmonary section exam
* Chest assessment/CV auscultation II 
Sept. 25 * Electrocardiography (ECG) I Dr. Ryan Mays
* ECG II Ryan Mays
Sept. 30 * Cardiovascular pharmacology Professor Vince Colucci
* ECG & Abnormal responses to  assessment
Oct. 2 * Cardiopulmonary patient assessment & treatm ent: Clinical Exercise Testing
* Cardiovascular assessment & therapeutic principles: CVD & HF 
Oct. 7 * Cardiopulmonary pharmacology Professor Vince Colucci
* Cardiovascular assessment & therapeutic principles: CVD & HF 
Oct. 9 * Cardiovascular assessment & therapeutic principles
*  Peripheral arterial disease Dr. Ryan Mays 
Oct 14 * Cardiovascular section exam
7
